Skip to main content

Table 2 Adequate clinical and parasitological response (ACPR) at day 28 (per-protocol population)

From: Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study

 

n

Success, n (%)

95 % CI

Age group 1 (6 months to <2 years)

19

19 (100.0)

82.35, 100.0

Age group 2 (2 to <6 years)

42

42 (100.0)

91.59, 100.0

Age group 3 (6 to ≤12 years)

65

65 (100.0)

94.48, 100.0

Overall age (6 months to ≤12 years)

126

126 (100.0)

97.11, 100.0